A Phase 1b Trial of LY2606368 in Combination With Chemoradiation in Patients With Locally Advanced Head and Neck Squamous Cell Cancer
Phase of Trial: Phase I
Latest Information Update: 06 Oct 2017
At a glance
- Drugs Prexasertib (Primary) ; Cetuximab; Cisplatin
- Indications Head and neck cancer
- Focus Adverse reactions
- Sponsors Eli Lilly
- 11 Oct 2016 Trial design presented at the 41st European Society for Medical Oncology Congress.
- 25 Feb 2016 Status changed from not yet recruiting to recruiting, according to ClinicalTrials.gov record.
- 11 Feb 2016 Planned initiation date changed from 1 Jan 2016 to 1 Mar 2016 as per ClinicalTrials.gov record.